Key clinical point: Transcatheter device offers potential in patients at prohibitive surgical risk.
Major finding: Mitral regurgitation was eliminated and quality of life scores greatly improved at 6 months’ follow-up in a feasibility study of the transcatheter Tendyne device for treatment of severe mitral annular calcification.
Study details: This was a feasibility study of the Tendyne transcatheter mitral valve device in 11 patients with severe mitral annular calcification at prohibitive surgical risk.
Disclosures: The presenter reported receiving research grants from and serving as a consultant to Abbott, the feasibility study sponsor, and other medical device companies.
Sorajja P. EuroPCR 2020.